Life
Briefing: Gene edit makes probiotic safer for immunocompromised patients
Strategic angle: An international team of researchers has modified a probiotic yeast to enhance safety for vulnerable populations.
editorial-staff
1 min read
Updated about 1 month ago
Summary
- Modified yeast reduces infection risk for immunocompromised individuals.
- Research conducted using animal models.
- Target groups include older adults and infants.
Key Facts
| Fact | Value |
|---|---|
| Research Team | International team of researchers |
| Target Population | Immunocompromised patients, older adults, infants |
| Testing Method | Animal model |